This PDF is the current document as it appeared on Public Inspection on 09/05/2013 at 08:45 am.
By Notice dated May 14, 2013 and published in the Federal Register on May 22, 2013, 78 FR 30331, Alltech Associates, Inc., 2051 Waukegan Road, Deerfield, Illinois 60015, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:
|4-Methylaminorex (cis isomer) (1590)||I|
|Lysergic acid diethylamide (7315)||I|
|2C-T-7 (2,5-Dimethoxy-4-(n)-Propylthiophenethylamine) (7348)||I|
|2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl)ethanamine) (7385)||I|
|Start Printed Page 54920|
|2C-E (2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine) (7509)||I|
|2C-H (2-(2,5-Dimethoxyphenyl)ethanamine) (7517)||I|
|2C-C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (7519)||I|
|2C-T-4 (2-4-isopropylthio)-2,5-dimethoxyphenyl ethanamine) (7532)||I|
|Meperidine intermediate-B (9233)||II|
The company plans to manufacture high purity drug standards used for analytical applications only in clinical, toxicological, and forensic laboratories.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Alltech Associates, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Alltech Associates, Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.Start Signature
Dated: August 29, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 2013-21750 Filed 9-5-13; 8:45 am]
BILLING CODE 4410-09-P